These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29268980)

  • 21. Antigenic variation of the human influenza A (H3N2) virus during the 2014-2015 winter season.
    Hua S; Li X; Liu M; Cheng Y; Peng Y; Huang W; Tan M; Wei H; Guo J; Wang D; Wu A; Shu Y; Jiang T
    Sci China Life Sci; 2015 Sep; 58(9):882-8. PubMed ID: 26219513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using sequence data to infer the antigenicity of influenza virus.
    Sun H; Yang J; Zhang T; Long LP; Jia K; Yang G; Webby RJ; Wan XF
    mBio; 2013 Jul; 4(4):. PubMed ID: 23820391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passage Adaptation Correlates With the Reduced Efficacy of the Influenza Vaccine.
    Chen H; Alvarez JJS; Ng SH; Nielsen R; Zhai W
    Clin Infect Dis; 2019 Sep; 69(7):1198-1204. PubMed ID: 30561532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
    DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
    Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.
    Monamele GC; Vernet MA; Njankouo MR; Victoir K; Akoachere JF; Anong D; Njouom R
    PLoS One; 2017; 12(9):e0184411. PubMed ID: 28877235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
    Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept.
    Erdman MM; Kamrud KI; Harris DL; Smith J
    Vaccine; 2010 Jan; 28(3):594-6. PubMed ID: 19853679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United States.
    Rajão DS; Gauger PC; Anderson TK; Lewis NS; Abente EJ; Killian ML; Perez DR; Sutton TC; Zhang J; Vincent AL
    J Virol; 2015 Nov; 89(22):11213-22. PubMed ID: 26311895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility.
    Wu NC; Lv H; Thompson AJ; Wu DC; Ng WWS; Kadam RU; Lin CW; Nycholat CM; McBride R; Liang W; Paulson JC; Mok CKP; Wilson IA
    Cell Host Microbe; 2019 Jun; 25(6):836-844.e5. PubMed ID: 31151913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and characterization of a cold-adapted attenuated live H3N2 subtype influenza virus vaccine candidate.
    An WQ; Yang PH; Duan YQ; Luo DY; Tang C; Jia WH; Xing L; Shi XF; Zhang YJ; Liu XF; Wang XL
    Chin Med J (Engl); 2009 Dec; 122(23):2880-5. PubMed ID: 20092795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seasonal antigenic prediction of influenza A H3N2 using machine learning.
    Shah SAW; Palomar DP; Barr I; Poon LLM; Quadeer AA; McKay MR
    Nat Commun; 2024 May; 15(1):3833. PubMed ID: 38714654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
    Chen Z; Zhou H; Jin H
    Vaccine; 2010 May; 28(24):4079-85. PubMed ID: 20399830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of epidemiological strains of influenza A virus (H3N2) isolate in 1997-1999. Virus A/Moscow/10/99--a candidate to become the vaccine strain].
    Slepushkin AN; Ivanova VT; Burtseva EI; Oskerko TA; Volodina TN; Kuribko SG; Kolobukhina LV; Beda MV
    Vopr Virusol; 2000; 45(4):22-4. PubMed ID: 10971961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemagglutinin stem reactive antibody response in individuals immunized with a seasonal influenza trivalent vaccine.
    Zhao X; Qin K; Guo J; Wang D; Li Z; Zhu W; Liu L; Wang D; Shu Y; Zhou J
    Protein Cell; 2015 Jun; 6(6):453-457. PubMed ID: 25940943
    [No Abstract]   [Full Text] [Related]  

  • 37. Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan.
    Sugaya N; Shinjoh M; Kawakami C; Yamaguchi Y; Yoshida M; Baba H; Ishikawa M; Kono M; Sekiguchi S; Kimiya T; Mitamura K; Fujino M; Komiyama O; Yoshida N; Tsunematsu K; Narabayashi A; Nakata Y; Sato A; Taguchi N; Fujita H; Toki M; Myokai M; Ookawara I; Takahashi T
    Euro Surveill; 2016 Oct; 21(42):. PubMed ID: 27784529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses.
    Neher RA; Bedford T; Daniels RS; Russell CA; Shraiman BI
    Proc Natl Acad Sci U S A; 2016 Mar; 113(12):E1701-9. PubMed ID: 26951657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe.
    de Jong JC; Smith DJ; Lapedes AS; Donatelli I; Campitelli L; Barigazzi G; Van Reeth K; Jones TC; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2007 Apr; 81(8):4315-22. PubMed ID: 17287258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.
    Wang S; Taaffe J; Parker C; Solórzano A; Cao H; García-Sastre A; Lu S
    J Virol; 2006 Dec; 80(23):11628-37. PubMed ID: 16987975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.